YD Bio (NASDAQ:YDES) Shares Up 5% – Here’s What Happened

YD Bio Limited (NASDAQ:YDES) shares shot up 5% during mid-day trading on Tuesday. The stock traded as high as $7.56 and last traded at $7.4650. 150,311 shares changed hands during mid-day trading, an increase of 7% from the average session volume of 140,894 shares. The stock had previously closed at $7.11.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised shares of YD Bio to a “hold” rating in a research report on Saturday, September 26th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has an average rating of “Sell”.

YD Bio Stock Performance

The stock has a 50-day moving average of $3.63 and a 200-day moving average of $4.16.

YD Bio (NASDAQ:YDES) last announced its quarterly earnings data on Tuesday, September 1st. The biotechnology company reported $0.05 earnings per share for the quarter. The company had revenue of $0.42 million during the quarter.

Institutional Investors Weigh In On YD Bio

An institutional investor recently raised its position in YD Bio stock. Cypress Capital Management LLC WY increased its position in shares of YD Bio Limited (NASDAQ:YDES) by 9.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 33,690 shares of the biotechnology company’s stock after acquiring an additional 3,000 shares during the period. Cypress Capital Management LLC WY’s holdings in YD Bio were worth $76,000 as of its most recent filing with the Securities and Exchange Commission.

About YD Bio

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.